| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.09 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |